<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP10183935B8W1" file="EP10183935W1B8.xml" lang="en" country="EP" doc-number="2294918" kind="B8" correction-code="W1" date-publ="20121114" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY....................................................</B001EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>2294918</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20121114</date></B140><B150><B151>W1</B151><B153>72 73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>10183935.5</B210><B220><date>20000829</date></B220><B240><B241><date>20100930</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260><B270><dnum><anum>08168000</anum></dnum><date>20000829</date><ctry>EP</ctry></B270></B200><B300><B310>385411</B310><B320><date>19990830</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20121114</date><bnum>201246</bnum></B405><B430><date>20110316</date><bnum>201111</bnum></B430><B450><date>20121010</date><bnum>201241</bnum></B450><B452EP><date>20120504</date></B452EP><B480><date>20121114</date><bnum>201246</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12N   9/22        20060101AFI20120208BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/46        20060101ALI20120208BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>Gebrauch einer Ribonuclease der T2-Familie mit Actin-bindender Aktivität zur Hemmung der Tumorangiogenese</B542><B541>en</B541><B542>Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting tumor angiogenesis</B542><B541>fr</B541><B542>Utilisation d'une ribonucléase de la famille t2 ayant une activité de fixation à l'actine pour inhiber l'angiogenèse de tumeurs</B542></B540><B560><B561><text>EP-B1- 1 207 755</text></B561><B561><text>WO-A2-2006/035439</text></B561><B561><text>US-A- 5 786 457</text></B561><B562><text>KAWATA-Y ET AL.: "AMINO-ACID SEQUENCE OF RIBONUCLEASE T2 FROM ASPERGILLUS ORYZAE", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 176, 1988, pages 683-697, XP002935748, Berlin, De</text></B562><B562><text>KAWATA Y ET AL: "IDENTIFICATION OF TWO ESSENTIAL HISTIDINE RESIDUES OF RNASE T-2 FROM ASPERGILLUS-ORYZAE", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 187, no. 1, 1990, pages 255-262, XP008009203, ISSN: 0014-2956</text></B562><B562><text>NOMACHI Y ET AL: "PURIFICATION AND SOME PROPERTIES OF 2 ACID RNASE FRACTIONS EC-3.1.27.1 EC-3.1.27.3 FROM THE MYCELIA OF ASPERGILLUS-NIGER", JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, vol. 26, no. 6, 1980, pages 375-386, XP008009205, ISSN: 0022-1260</text></B562><B562><text>LACCETTI P ET AL: "SEMINAL RIBONUCLEASE INHIBITS TUMOR GROWTH AND REDUCES THE METASTATIC POTENTIAL OF LEWIS LUNG CARCINOMA", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 54, 15 August 1994 (1994-08-15), pages 4253-4256, XP002000755, ISSN: 0008-5472</text></B562><B562><text>IRIE M: "STRUCTURE-FUNCTION RELATIONSHIPS OF ACID RIBONUCLEASES: LYSOSOMAL, VACUOLAR, AND PERIPLASMIC ENZYMES", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, vol. 81, no. 2, 1 January 1999 (1999-01-01), pages 77-89, XP002935746, ISSN: 0163-7258</text></B562><B562><text>MASTRONICOLA M R ET AL: "Key extracellular and intracellular steps in the antitumor action of seminal ribonuclease.", EUROPEAN JOURNAL OF BIOCHEMISTRY / FEBS 15 MAY 1995, vol. 230, no. 1, 15 May 1995 (1995-05-15), pages 242-249, XP002565611, ISSN: 0014-2956</text></B562><B562><text>TRUBIA M ET AL: "Mammalian Rh/T2/S-Glycoprotein Ribonuclease Family Genes: Cloning of a Human Member Located in a Region of Chromosome 6 (6q27) Frequently Deleted in Human Malignancies", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 42, no. 2, 1 June 1997 (1997-06-01), pages 342-344, XP004459303, ISSN: 0888-7543</text></B562><B562><text>FETT J W ET AL: "Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.", BIOCHEMISTRY 24 SEP 1985 LNKD- PUBMED:4074709, vol. 24, no. 20, 24 September 1985 (1985-09-24), pages 5480-5486, XP002618087, ISSN: 0006-2960</text></B562><B562><text>ACQUATI FRANCESCO ET AL: "Tumor and metastasis suppression by the human RNASET2 gene.", INTERNATIONAL JOURNAL OF ONCOLOGY MAY 2005, vol. 26, no. 5, May 2005 (2005-05), pages 1159-1168, XP009068627, ISSN: 1019-6439</text></B562><B562><text>LELAND P A ET AL: "Cancer chemotherapy--ribonucleases to the rescue.", CHEMISTRY &amp; BIOLOGY MAY 2001, vol. 8, no. 5, May 2001 (2001-05), pages 405-413, XP002565612, ISSN: 1074-5521</text></B562><B562><text>DESHPANDE R A ET AL: "RIBONUCLEASES FROM T2 FAMILY", CRITICAL REVIEWS IN MICROBIOLOGY, CRC PRESS, INC., BOCA RATON, FL, US, vol. 28, no. 2, 1 June 2002 (2002-06-01), pages 79-122, XP008009078,</text></B562><B562><text>LUHTALA NATALIE ET AL: "T2 Family ribonucleases: ancient enzymes with diverse roles.", TRENDS IN BIOCHEMICAL SCIENCES MAY 2010 LNKD- PUBMED:20189811, vol. 35, no. 5, May 2010 (2010-05), pages 253-259, XP002618088, ISSN: 0968-0004</text></B562><B562><text>ROIZ LEVAVA ET AL: "ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics.", CANCER 15 MAY 2006 LNKD- PUBMED:16586499, vol. 106, no. 10, 15 May 2006 (2006-05-15) , pages 2295-2308, XP002618089, ISSN: 0008-543X</text></B562></B560></B500><B600><B620><parent><pdoc><dnum><anum>08168000.1</anum><pnum>2165605</pnum></dnum><date>20081031</date></pdoc><pdoc><dnum><anum>00954879.3</anum><pnum>1207755</pnum></dnum><date>20000829</date></pdoc></parent></B620></B600><B700><B720><B721><snm>Roiz, Levava</snm><adr><str>
9/38 Shaul HaMelech Street</str><city>55654, Kiryat-Ono</city><ctry>IL</ctry></adr></B721><B721><snm>Shoseyov, Oded</snm><adr><str>
5 Erez Street</str><city>99797, Karmei Yosef</city><ctry>IL</ctry></adr></B721><B721><snm>Schwartz, Betty</snm><adr><str>
6/2 Itzhak Ben-Ari Road</str><city>76667, Rechovot</city><ctry>IL</ctry></adr></B721><B721><snm>Smirnoff, Patricia</snm><adr><str>
17/7 Glazer Street</str><city>76823, Rehovot</city><ctry>IL</ctry></adr></B721></B720><B730><B731><snm>Yissum Research Development Company of the Hebrew 
University of Jerusalem Ltd.</snm><iid>101135792</iid><irf>F-11982/EP/3</irf><adr><str>Hi Tech Park 
The Edmond J. Safra Campus 
The Hebrew University of Jerusalem 
Givat Ram</str><city>91390 Jerusalem</city><ctry>IL</ctry></adr></B731></B730><B740><B741><snm>Fichter, Robert Arno</snm><iid>101045029</iid><adr><str>Dennemeyer &amp; Associates S.A. 
55, rue des Bruyères</str><city>1274 Howald</city><ctry>LU</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B880><date>20110316</date><bnum>201111</bnum></B880></B800></SDOBI>
</ep-patent-document>
